Cyclops
Disposable dry powder inhaler

Cyclops
Disposable dry powder inhaler


Cyclops™ is an easy-to-use, pre-filled, disposable DPI that is developed for inhalation powders and can be produced in a cost-effective way because of its simple yet sophisticated proprietary design.
Upon inhalation it uses the patient’s breath to disperse the dry powder formulation into small particles appropriately sized for deep lung deposition. Cyclops™ has several advantages compared to standard-of-care DPIs across key therapeutic areas. These attributes enable the hygienic and effective use on a worldwide scale. One product, Colistin Cyclops™, is already marketed and reimbursed under a named patient regimen for the treatment of cystic fibrosis patients.
HIGHLY PREFERRED BY PATIENTS
Latest news

Colistin Cyclops® Gains EMA and FDA Orphan Drug Status in Cystic Fibrosis
EMA as well as FDA recently designated PureIMS’s colistin dry
December 17, 2024

CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS
Fagron and PureIMS have joined forces to make CYCLOPS® dry
September 26, 2024

International Congress of Parkinson’s Disease and Movement Disorders 2024 – poster on Levodopa Cyclops®
Please check out our latest poster (#708) presenting clinical study
September 18, 2024
Press release
17 December 2024
Press release
26 September 2024
Scientific publication
18 September 2024